Y Tada Selected Research

Melanoma (Melanoma, Malignant)

1/2014	Combination of adenoviruses expressing melanoma differentiation-associated gene-7 and chemotherapeutic agents produces enhanced cytotoxicity on esophageal carcinoma.
11/2008	Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Y Tada Research Topics

Disease

17	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2022 - 03/2001
15	Neoplasms (Cancer) 09/2020 - 01/2000
8	Atopic Dermatitis (Atopic Eczema) 11/2019 - 05/2000
6	Carcinoma (Carcinomatosis) 09/2020 - 02/2000
6	Systemic Scleroderma (Systemic Sclerosis) 12/2016 - 03/2003
6	Fibrosis (Cirrhosis) 12/2016 - 03/2001
5	Necrosis 01/2020 - 07/2000
5	Inflammation (Inflammations) 03/2016 - 04/2012
5	Skin Diseases (Skin Disease) 03/2016 - 01/2001
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2012 - 01/2005
4	Rheumatoid Arthritis 01/2022 - 03/2016
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2022 - 08/2011
3	Prostatic Neoplasms (Prostate Cancer) 06/2010 - 01/2000
2	Pulmonary Arterial Hypertension 09/2015 - 01/2013
2	Rupture 01/2015 - 02/2000
2	Mesothelioma 11/2014 - 03/2012
2	Melanoma (Melanoma, Malignant) 01/2014 - 11/2008
2	Insulin Resistance 03/2013 - 04/2012
2	Leukemia 11/2012 - 02/2001
2	Sclerosis 11/2012 - 03/2012
2	Bullous Pemphigoid (Pemphigoid) 04/2007 - 01/2007
2	Osteonecrosis (Kienbock's Disease) 01/2006 - 01/2005
2	Anemia 09/2004 - 08/2001
2	Methemoglobinemia 09/2004 - 07/2000
2	Splenomegaly 09/2004 - 07/2000
2	False Aneurysm (Pseudoaneurysm) 03/2003 - 02/2000
2	Breast Neoplasms (Breast Cancer) 08/2001 - 01/2000
2	Infections 05/2001 - 04/2001
2	Hyperplasia 03/2001 - 07/2000
2	Aneurysm (Aneurysms) 02/2001 - 02/2000
1	Otitis Media 03/2022
1	Rheumatic Diseases (Rheumatism) 01/2021
1	Opioid-Induced Constipation 06/2018
1	Muscle Cramp (Cramp) 12/2016
1	Psoriatic Arthritis 03/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2016
1	Chronic Renal Insufficiency 09/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2015

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 10/2014 - 06/2001
5	InterleukinsIBA 01/2021 - 06/2006
4	Androgen Receptors (Androgen Receptor)IBA 09/2020 - 01/2010
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2006 - 09/2000
3	Interleukin-12 (IL 12)IBA 07/2013 - 05/2000
3	EnzymesIBA 01/2013 - 08/2012
3	ImmunosorbentsIBA 01/2013 - 08/2012
3	Prednisolone (Predate)FDA LinkGeneric 01/2005 - 04/2000
3	HemosiderinIBA 09/2004 - 07/2000
2	dupilumabIBA 03/2022 - 11/2019
2	Antirheumatic Agents (DMARD)IBA 01/2022 - 01/2020
2	AntigensIBA 01/2021 - 10/2015
2	ixekizumabIBA 01/2021 - 01/2020
2	guselkumabIBA 01/2021 - 01/2020
2	Abatacept (Orencia)FDA Link 01/2021 - 01/2020
2	Interleukin-23 (Interleukin 23)IBA 01/2020 - 07/2013
2	AndrogensIBA 01/2018 - 06/2010
2	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 04/2001
2	MidkineIBA 09/2015 - 03/2001
2	Lipocalin-2IBA 09/2015 - 04/2012
2	AdipokinesIBA 09/2015 - 03/2013
2	Cisplatin (Platino)FDA LinkGeneric 06/2015 - 03/2012
2	Pharmaceutical PreparationsIBA 01/2015 - 01/2001
2	Proteins (Proteins, Gene)FDA Link 11/2014 - 04/2012
2	ChemokinesIBA 10/2014 - 08/2011
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2013 - 06/2006
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 03/2013 - 03/2012
2	Chemokine CCL17IBA 01/2013 - 03/2001
2	AdiponectinIBA 03/2012 - 03/2011
2	LigandsIBA 04/2007 - 01/2007
2	SteroidsIBA 01/2006 - 01/2005
2	Chlorpropham (CIPC)IBA 09/2004 - 07/2000
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2000 - 01/2000
1	tildrakizumabIBA 10/2022
1	mepolizumabIBA 03/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Janus KinasesIBA 01/2022
1	Vitamin D FDA LinkGeneric 02/2021
1	GlucocorticoidsIBA 02/2021
1	Interleukin-23 Subunit p19IBA 01/2021
1	AntibodiesIBA 01/2021
1	human ERBB2 proteinIBA 09/2020
1	Tumor Necrosis Factor InhibitorsIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Anti-Citrullinated Protein AntibodiesIBA 01/2020
1	secukinumabIBA 12/2018
1	naldemedineIBA 06/2018
1	Narcotic Antagonists (Opioid Antagonists)IBA 06/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2016
1	CathelicidinsIBA 12/2016
1	Interleukin-33IBA 03/2016
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2015
1	CaspasesIBA 09/2015
1	SurvivinIBA 09/2015

Therapy/Procedure

11	Therapeutics 02/2021 - 01/2000
3	Drug Therapy (Chemotherapy) 01/2018 - 02/2000
2	Oral Administration 01/2015 - 05/2000
2	Castration 06/2010 - 01/2010
2	Ligation 03/2003 - 08/2001
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 05/2001 - 09/2000
1	Aftercare (After-Treatment) 01/2021
1	Immunotherapy 10/2015